Long-term success treating inflammatory epiretinal neovascularization with immunomodulatory therapy

Fatma Zaguia, Alessandro Marchese, Maria Vittoria Cicinelli, Victoria J. Miller, Elisabetta Miserocchi, Debra A. Goldstein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Purpose: This study aims to report the long-term outcomes of uveitis-associated optic disc and epiretinal neovascularization (NV) treated with immunomodulatory therapy alone. Methods: This is a retrospective, multi-center chart review conducted at Northwestern University (Chicago, IL) and San Raffaele Scientific Institute (Milan, Italy) from 2014 to 2021 of patients with optic disc and/or retinal neovascularization associated with uveitis. The data collected included age at the time of NV detection, gender, medications, and follow-up period. Imaging was reviewed if available. Results: Eight eyes of six patients were identified. The mean age was 22 years (range 10–52 years); the median follow-up was 3 years (range 6 months to 7 years). All eyes presented with active NV at the time of uveitis onset; 7 eyes were treatment-naïve. None had clinical or angiographic evidence of retinal ischemia. All patients received a variable combination of local steroids, systemic steroids, and systemic immunosuppression. Complete resolution of uveitic NV occurred in all eyes within a median of 8 weeks (ranging 2–20 weeks) from initiating treatment. No NV recurrence was noted. Conclusion: Immunomodulatory therapy alone may be successful in achieving long-term control of uveitis-associated NV, without the use of destructive measures.

Original languageEnglish (US)
Pages (from-to)553-559
Number of pages7
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Issue number2
StatePublished - Feb 2022


  • Immunomodulatory therapy
  • Inflammatory eye disease
  • Optic disc neovascularization
  • Retinal neovascularization
  • Uveitis

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Long-term success treating inflammatory epiretinal neovascularization with immunomodulatory therapy'. Together they form a unique fingerprint.

Cite this